Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EXAS – Exact Sciences Corporation

Exact Sciences Corporation
EXAS
$53.65
Name : Exact Sciences Corporation
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $10,120,428,544.00
EPSttm : -5.53
finviz dynamic chart for EXAS
Exact Sciences Corporation
$53.65
3.55%
$1.84

Float Short %

4.27

Margin Of Safety %

-25

Put/Call OI Ratio

1.09

EPS Next Q Diff

0.68

EPS Last/This Y

5.8

EPS This/Next Y

0.79

Price

53.68

Target Price

68.96

Analyst Recom

1.43

Performance Q

19.25

Relative Volume

3.07

Beta

0.96

Ticker: EXAS




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02EXAS56.120.823.3144671
2025-06-03EXAS54.840.870.1645830
2025-06-04EXAS55.160.830.6647553
2025-06-05EXAS54.380.840.6947278
2025-06-06EXAS54.880.840.7747260
2025-06-09EXAS54.610.840.4947032
2025-06-10EXAS56.170.841.0447279
2025-06-11EXAS55.650.840.0547477
2025-06-12EXAS53.990.781.3949600
2025-06-13EXAS53.530.770.4649729
2025-06-16EXAS53.270.770.2349266
2025-06-17EXAS52.470.770.5249460
2025-06-18EXAS52.330.760.8950007
2025-06-20EXAS52.970.760.5050107
2025-06-23EXAS52.540.901.0136386
2025-06-24EXAS51.190.910.7537025
2025-06-25EXAS51.911.001.4342357
2025-06-26EXAS51.81.030.7745787
2025-06-27EXAS53.671.091.2446945
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02EXAS56.12213.81037.50.22
2025-06-03EXAS54.84213.81036.70.22
2025-06-04EXAS55.16213.81037.80.22
2025-06-05EXAS54.38213.81037.00.21
2025-06-06EXAS54.87213.81037.90.21
2025-06-09EXAS54.63213.81037.40.21
2025-06-10EXAS56.15213.81038.60.21
2025-06-11EXAS55.65213.81037.20.21
2025-06-12EXAS54.01213.81036.50.21
2025-06-13EXAS53.53213.81037.20.21
2025-06-16EXAS53.29213.81037.40.21
2025-06-17EXAS52.54213.81037.00.21
2025-06-18EXAS52.34213.81037.40.21
2025-06-20EXAS53.02213.81038.00.21
2025-06-23EXAS52.57213.81044.90.21
2025-06-24EXAS51.18213.81044.10.21
2025-06-25EXAS51.90- 1045.80.00
2025-06-26EXAS51.80- 1045.10.00
2025-06-27EXAS53.68193.51046.80.21
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02EXAS0.000.145.99
2025-06-03EXAS0.000.145.99
2025-06-04EXAS0.000.145.99
2025-06-05EXAS0.000.145.99
2025-06-06EXAS0.000.145.99
2025-06-09EXAS0.000.145.99
2025-06-10EXAS0.000.145.99
2025-06-11EXAS0.000.145.74
2025-06-12EXAS0.000.145.74
2025-06-13EXAS0.000.145.74
2025-06-16EXAS0.000.205.74
2025-06-18EXAS-0.110.205.74
2025-06-20EXAS-0.110.205.74
2025-06-23EXAS-0.110.185.74
2025-06-24EXAS-0.110.185.74
2025-06-25EXAS-0.110.185.74
2025-06-26EXAS-0.110.184.27
2025-06-27EXAS-0.110.184.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

-0.54

Avg. EPS Est. Current Quarter

0.05

Avg. EPS Est. Next Quarter

0.14

Insider Transactions

-0.11

Institutional Transactions

0.18

Beta

0.96

Average Sales Estimate Current Quarter

774

Average Sales Estimate Next Quarter

796

Fair Value

40.51

Quality Score

40

Growth Score

49

Sentiment Score

41

Actual DrawDown %

66.4

Max Drawdown 5-Year %

-80.4

Target Price

68.96

P/E

Forward P/E

145.74

PEG

P/S

3.58

P/B

4.22

P/Free Cash Flow

52.13

EPS

-5.5

Average EPS Est. Cur. Y​

0.21

EPS Next Y. (Est.)

1

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-36.06

Relative Volume

3.07

Return on Equity vs Sector %

-66.5

Return on Equity vs Industry %

-53.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

1046.8
Exact Sciences Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 6900
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today
news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance
stock history EXAS – Exact Sciences Corporation invest stock market
stock prices EXAS premarket after hours
ticker EXAS fair value insiders trading